DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/61183d/womens_health_the) has announced the addition of the "Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/8cd614/global_coronary_st) has announced the addition of the "Global Coronary Stent Market Report: 2010 Edition" report to their offering. Global Coronary Stent Market Report: 2010 Edition (…)
[Read article]
[Source: Business Wire]
STOCKHOLM, September 2, 2010 /PRNewswire/ - Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions. Three new analyses of subgroups from (…)
[Read article]
[Source: BioSpace]
MIAMI, FL-(Marketwire - September 1, 2010) - Unity Management Group, Inc. (PINKSHEETS: UYMG) is a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies. Unity Management (…)
[Read article]
[Source: Marketwire]
YOKNEAM, ISRAEL-(Marketwire - September 1, 2010) - Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today that Asaf Alperovitz has been appointed Chief Financial Officer, effective immediately. Mr. Alperovitz succeeds Fabian (…)
[Read article]
[Source: Marketwire]
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of recurrent venous thromboembolism (VTE) (…)
[Read article]
[Source: Medical News Today]
LEXINGTON, Mass. & HUNGERFORD, England-(BUSINESS WIRE)-GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced it has entered into a new agreement with Elemental Healthcare, based in Hungerford, Berkshire, for the (…)
[Read article]
[Source: Business Wire]
FT LAUDERDALE, Fla.-(BUSINESS WIRE)-As the State of Florida grapples with a budget shortfall that is crippling its AIDS Drug Assistance Program (ADAP) and forcing the state to place more than 1,300 low-income Floridians on waiting lists to access lifesaving AIDS medications, (…)
[Read article]
[Source: Business Wire]
DURHAM, NC - September 1, 2010 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the appointment of Robert M. Savel, II, to the position of Senior Vice President and Chief Technical Officer, effective September 20, 2010. In this role, Mr. Savel will be responsible (…)
[Read article]
[Source: BioSpace]
STOCKHOLM-(BUSINESS WIRE)-Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced today that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of (…)
[Read article]
[Source: Business Wire]
NEWARK, N.J.-(BUSINESS WIRE)-The Horizon Foundation for New Jersey announced today that it has been chosen as one of nine foundations nationwide to receive funding from Partners Investing in Nursing s Future (PIN), a unique national initiative to help find innovative ways to (…)
[Read article]
[Source: Business Wire]
BUSINESS WIRE - Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced today that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of recurrent venous (…)
[Read article]
[Source: BioSpace]
STOCKHOLM-(BUSINESS WIRE)-Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), announced today that the investigational, oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care1 for the prevention of (…)
[Read article]
[Source: BioSpace]
BRISTOL, TN-(Marketwire - August 30, 2010) - King Pharmaceuticals, Inc. (NYSE: KG) announced today the appointment of Jeffrey A. Bailey to the position of Chief Commercial Officer. Mr. Bailey will be responsible for the Company's commercial activities in the branded (…)
[Read article]
[Source: Marketwire]
PORTLAND, Maine-(BUSINESS WIRE)-With well over 100 attendees already registered, IntertechPira s 5th annual Biopolymers Symposium 2010 is the industry's market leading event where new technologies, trends, developments in applications, new guidelines and waste strategies are (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/37adf0/eli_lilly_co_p) has announced the addition of the "Eli Lilly & Co.: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Elan Corporation, plc ( Elan ) (NYSE: ELN) announced today that Elan s wholly-owned subsidiaries, Elan Finance public limited company ( Elan Finance ) and Elan Finance Corp. ( Elan Corp and together with Elan Finance, the Issuers ), (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/aabcf1/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
American Association of Colleges of Nursing (AACN) is pleased to announce that five new Minority Nurse Faculty Scholars have been selected through a national scholarship program funded by the Johnson & Johnson Campaign for Nursing's Future. Launched to address the faculty (…)
[Read article]
[Source: Medical News Today]
Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/b3640f/germany_opthalmic) has announced the addition of GlobalData's new report "Germany Opthalmic Devices Market Outlook to 2016" to their offering. Germany Opthalmic Devices Market (…)
[Read article]
[Source: Business Wire]
LOS ANGELES-(BUSINESS WIRE)-The Lanier Law Firm is providing information for patients following the announcement that Johnson & Johnson (NYSE: JNJ) is recalling two hip replacement implants based on the high number of people requiring a second surgery. Attorneys from the firm (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/883f56/novel_antibodies_a) has announced the addition of the "Novel Antibodies and Therapeutic Proteins - Technology Challenges and Future Prospects" report to their offering. Novel (…)
[Read article]
[Source: Business Wire]
BASEL, SWITZERLAND-(Marketwire - August 27, 2010) - Basilea Pharmaceutica AG / Basilea announces distribution agreement with Actelion for Toctino in Canada processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Basel, (…)
[Read article]
[Source: BioSpace]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/82abf7/italy_opthalmic_de) has announced the addition of GlobalData's new report "Italy Opthalmic Devices Market Outlook to 2016" to their offering. Italy Opthalmic Devices Market Outlook (…)
[Read article]
[Source: Business Wire]
LANSDALE, Pa.-(BUSINESS WIRE)-CRF Health, a leading provider of ePRO solutions for the Life Sciences industry, today announced that Bonnie Teschendorf, Ph.D. has joined the Company as Patient Reported Outcomes Scientific Advisor. She will lead CRF Health s PRO consulting (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/128b00/spain_opthalmic_de) has announced the addition of GlobalData 's new report "Spain Opthalmic Devices Market Outlook to 2016" to their offering. Spain Opthalmic Devices Market Outlook (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/7c5055/israel_wound_care) has announced the addition of GlobalData's new report "Israel Wound Care Management Market Outlook to 2016" to their offering. Israel Wound Care Management Market (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/360241/best_practices_in) has announced the addition of the "Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships" report to their offering. Best (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/4c0b13/france_opthalmic_d) has announced the addition of GlobalData 's new report "France Opthalmic Devices Market Outlook to 2016" to their offering. France Opthalmic Devices Market (…)
[Read article]
[Source: Business Wire]
One in 10 infants in the U.S. have undetected vision problems, ranging from crossed eyes to cancer. While most parents know eye and vision problems can be detected in children before they're a year old, only 19 percent of those who participated in the American Optometric (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/4b4c71/commercial_insight) has announced the addition of the "Commercial Insight: Cytotoxic Therapies - Drug launches in rare indications to offset the decline in cytotoxic sales" report (…)
[Read article]
[Source: Business Wire]
WASHINGTON-(BUSINESS WIRE)-Today, the American Association of Colleges of Nursing (AACN) is pleased to announce that five new Minority Nurse Faculty Scholars have been selected through a national scholarship program funded by the Johnson & Johnson Campaign for Nursing s (…)
[Read article]
[Source: Business Wire]
GENEVA, SWITZERLAND-(Marketwire - August 25, 2010) - Addex Pharmaceuticals / Addex Partner Completes ADX71149 Phase I Program processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Geneva, Switzerland, 25 August 2010 - (…)
[Read article]
[Source: BioSpace]
ROCKVILLE, MD-(Marketwire - August 23, 2010) - MarketResearch.com has announced the addition of Espicom Healthcare Intelligence's new report "The Medical Device Market: USA" to their collection of Medical Devices market reports. For more information, visit (…)
[Read article]
[Source: Marketwire]
Highlighted Links PROVON Skin Care Toolkit AKRON, OH-(Marketwire - August 24, 2010) - With inspiration from directors of nursing, GOJO Industries has launched its refreshed line of PROVON products for residents of long-term care facilities. The PROVON line includes perineal (…)
[Read article]
[Source: Marketwire]
1 Day Acuvue contact lenses have been recalled by Johnson & Johnson (J&J) in 24 countries, not including the USA or Canada, following reports of irritation, stinging and pain among some users. J&J described the incident as "an isolated issue in one portion of the lens rinsing (…)
[Read article]
[Source: Medical News Today]
An estimated 20 million people in northwest Pakistan have been displaced by the worst flooding in decades. In response, Heart to Heart International has already sent an initial shipment of aid valued at $150,000 (U.S. wholesale) through its humanitarian partner, International (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/504cfd/australia_pharmace) has announced the addition of the "Australia Pharmaceutical Market Overview - Reforms and continued price cuts will change the healthcare landscape" report to (…)
[Read article]
[Source: Business Wire]
NEWTON, Mass.-(BUSINESS WIRE)-Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that Centocor R&D, Inc., a subsidiary of Johnson & Johnson, won a CIO 100 Award for tranSMART, a research data management system (…)
[Read article]
[Source: Business Wire]
In western countries, the use of a balloon-expandable covered stent is recommended for the treatment of native coarctation of the aorta (CoA) in adult patients because endovascular bare stents cannot completely prevent complications such as aneurysms or aortic rupture. However, (…)
[Read article]
[Source: NCBI PubMed]
NEWTON, Mass.-(BUSINESS WIRE)-Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that Centocor R&D, Inc., a subsidiary of Johnson & Johnson, won a CIO 100 Award for tranSMART, a research data management system (…)
[Read article]
[Source: BioSpace]